FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to new compounds of formula I and their pharmaceutically acceptable salts, method for preparing them by the fermentation of a microorganism of the species Streptomyces (PM0626271/MTCC 5447), and to their pharmaceutical compositions containing one or more compounds of formula I as an active ingredient.
EFFECT: compounds of formula I are used for treating and preventing the diseases caused by bacterial infections.
4 cl, 3 dwg, 6 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL ANTIBACTERIAL COMPOUNDS | 2007 |
|
RU2444526C2 |
| COMPOUNDS AND METHODS FOR TREATMENT OF INFECTIONS | 2018 |
|
RU2779024C2 |
| 5-HYDROXYMETHYLOXAZOLIN-2-ONE DERIVATIVES FOR TREATING BACTERIAL INTESTINAL DISEASES | 2009 |
|
RU2527769C2 |
| COMPOUNDS AND METHODS OF TREATING INFECTIONS | 2014 |
|
RU2666540C2 |
| HYDROXYALKYLTHIADIAZOLE DERIVATIVES | 2016 |
|
RU2737892C1 |
| PYRIMIDINE GYRASE AND TOPOISOMERASE IV INHIBITORS | 2012 |
|
RU2609259C2 |
| APPLICATION OF 4-(PYRROLIDINE-1-YL)QUINOLINE COMPOUNDS FOR ELIMINATION OF CLINICALLY LATENT MICROORGANISMS | 2008 |
|
RU2520766C2 |
| KIBDELOS PORANGIUM EXTRACTS AS ANTIBACTERIAL AGENTS | 2010 |
|
RU2572621C2 |
| METHODS OF TREATING BACTERIAL INFECTIONS | 2014 |
|
RU2666605C2 |
| SOLID FORMS OF GYRASE INHIBITOR (R)-1-ETHYL-3-[6-FLUORO-5-[2-(1-HYDROXY-1-METHYL-ETHYL) PYRIMIDIN-5-YL]-7-(TETRAHYDROFURAN-2-YL)-1H-BENZIMIDAZOL-2-YL] UREA | 2012 |
|
RU2625305C2 |
